These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 31759691)

  • 1. Intralesional methotrexate used in cutaneous Rosai-Dorfman disease.
    Nieto-Benito LM; Suárez-Fernández RM; Baniandrés-Rodríguez O
    Med Clin (Barc); 2020 Dec; 155(12):564-565. PubMed ID: 31759691
    [No Abstract]   [Full Text] [Related]  

  • 2. Cutaneous Rosai-Dorfman disease.
    Gaul M; Chang T
    Cutis; 2019 Mar; 103(3):171-173. PubMed ID: 31039225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cutaneous Rosai-Dorfman disease: comprehensive review of cases reported in the medical literature since 1990 and presentation of an illustrative case.
    Frater JL; Maddox JS; Obadiah JM; Hurley MY
    J Cutan Med Surg; 2006; 10(6):281-90. PubMed ID: 17241598
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cutaneous Rosai-Dorfman disease successfully treated with low-dose methotrexate.
    Sun NZ; Galvin J; Cooper KD
    JAMA Dermatol; 2014 Jul; 150(7):787-8. PubMed ID: 24789266
    [No Abstract]   [Full Text] [Related]  

  • 5. Successful treatment of large cutaneous facial Rosai-Dorfman disease using combination of subtotal resection and ALA-PDT: A case report.
    Wan M; Ding A; Liu H; Ou J; Zhang J
    Photodiagnosis Photodyn Ther; 2020 Sep; 31():101879. PubMed ID: 32562733
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cutaneous Rosai-Dorfman disease.
    Ohnishi A; Yoshida Y; Yamamoto O
    J Dermatol; 2008 Sep; 35(9):604-5. PubMed ID: 18837709
    [No Abstract]   [Full Text] [Related]  

  • 7. Response of cutaneous Rosai-Dorfman disease to topical and intralesional steroids.
    Satter EK; Graham BS; Steger JW
    Br J Dermatol; 2003 Sep; 149(3):672-4. PubMed ID: 14511018
    [No Abstract]   [Full Text] [Related]  

  • 8. [Purely cutaneous Rosai-Dorfman disease].
    Plettenberg H; Artik S; Kuhn A; Megahed M; Ruzicka T; Kruse R
    Hautarzt; 2004 Oct; 55(10):969-71. PubMed ID: 15351867
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Indolent firm reddish papules. Cutaneous Rosai-Dorfman disease].
    Bens G; Kerdraon R; De Kyvon JJ; Estève E
    Hautarzt; 2011 May; 62(5):384-7. PubMed ID: 21431448
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cutaneous Rosai-Dorfman Disease Located on the Breast: Rapid Effectiveness of Methotrexate After Failure of Topical Corticosteroids, Acitretin and Thalidomide.
    Nadal M; Kervarrec T; Machet MC; Petrella T; Machet L
    Acta Derm Venereol; 2015 Jul; 95(6):758-9. PubMed ID: 25632986
    [No Abstract]   [Full Text] [Related]  

  • 11. Low-dose weekly methotrexate used to treat cutaneous Rosai-Dorfman disease.
    Subash JJ; Kesty C; Kesty KR; Asgari M; Jorizzo J
    Clin Exp Dermatol; 2018 Oct; 43(7):849-851. PubMed ID: 29869440
    [No Abstract]   [Full Text] [Related]  

  • 12. Atypical Primary Cutaneous Rosai Dorfman Disease: A Case Report.
    Kinio AE; Sawchuk MA; Pratt M
    J Cutan Med Surg; 2017; 21(5):460-463. PubMed ID: 28639453
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Multiple nodules and plaques on the face and trunk. Cutaneous Rosai-Dorfman disease (RDD).
    Wartman DG; Perry A; Werchniak AE
    Arch Dermatol; 2006 Nov; 142(11):1501-6. PubMed ID: 17116845
    [No Abstract]   [Full Text] [Related]  

  • 14. Fractional laser combined with 5-Aminolevulinic acid photodynamic therapy for the treatment of Cutaneous Rosai-Dorfman Disease: A case report.
    Wang H; Wang C; Wang X; Zhang L; Zhang M; Ge L; You Y
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103852. PubMed ID: 37858909
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cutaneous Rosai-Dorfman disease after Covid 19 vaccination treated with thalidomide.
    Grimaldi M; Perino F; Moretta G; Antonelli F; Paradisi A; Ricci F; Abeni D; Didona B; Fania L
    Dermatol Ther; 2022 Nov; 35(11):e15864. PubMed ID: 36175132
    [No Abstract]   [Full Text] [Related]  

  • 16. Facial Cutaneous Rosai-Dorfman Disease.
    Flores-Terry MÁ; Romero-Aguilera G; González-López L; García-Arpa M
    Actas Dermosifiliogr; 2017 Jun; 108(5):480-482. PubMed ID: 28109522
    [No Abstract]   [Full Text] [Related]  

  • 17. Cutaneous Rosai-Dorfman disease: a systematic review and reappraisal of its treatment and prognosis.
    Dhrif O; Litaiem N; Lahmar W; Fatnassi F; Slouma M; Zeglaoui F
    Arch Dermatol Res; 2024 Jun; 316(7):393. PubMed ID: 38878198
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extranodal Rosai-Dorfman disease with cutaneous, ophthalmic and laryngeal involvement: report of a case treated with isotretinoin.
    Chang LY; Kuo TT; Chan HL
    Int J Dermatol; 2002 Dec; 41(12):888-91. PubMed ID: 12492979
    [No Abstract]   [Full Text] [Related]  

  • 19. Rosai-Dorfman disease presenting with nasal, nodal and multiple cutaneous involvements responding to a combination of systemic steroid and low-dose thalidomide therapy.
    Kalay Yildizhan I; Sanli H; Akay BN; Erol HM; Kuzu I; Kırmızı A; Cengiz Seval G
    Dermatol Ther; 2021 Jul; 34(4):e14988. PubMed ID: 33993590
    [No Abstract]   [Full Text] [Related]  

  • 20. Refractory cutaneous Rosai-Dorfman disease responsive to cryotherapy.
    Fumerton R; Ball N; Zhou Y
    Cutis; 2011 Jun; 87(6):296-9. PubMed ID: 21838087
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.